The Discounted Cash Flow (DCF) valuation of Fujian Aonong Biological Technology Group Incorporation Ltd (603363.SS) is 5.17 CNY. With the latest stock price at 3.77 CNY, the upside of Fujian Aonong Biological Technology Group Incorporation Ltd based on DCF is 37.1%.
Based on the latest price of 3.77 CNY and our DCF valuation, Fujian Aonong Biological Technology Group Incorporation Ltd (603363.SS) is a buy. buying 603363.SS stocks now will result in a potential gain of 37.1%.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 10.4% | 9.0% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 3.69 - 8.23 | 5.17 |
| Upside | -2.2% - 118.2% | 37.1% |